Marucci, M. A., D. W. Lechner, and B. A. Tafuto. “Safety Outcomes of Low Versus High Dose Imatinib Mesylate in Patients With Advanced, Metastatic, or Nonresectable Gastrointestinal Stromal Tumors: A Systematic Review”. Gastrointestinal Tract, vol. 2, no. 1, Mar. 2024, doi:10.54844/git.2023.482.